Acquisition Announced
Eli Lilly and Company acquisition of AttaiBeckley
US$3.8bn consideration
Announced 2026 (approx.)
Advisers
Eli Lilly and Company
Acquirer
Not disclosed
- Target
- AttaiBeckley
- Acquirer
- Eli Lilly and Company
- Target based in
- Germany (unverified)
- Buyer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development, Behavioral Health
In the league tables
Similar deals
- Eli Lilly and Company acquisition of AtaiBeckley Jul 2026 · US$2.8bn · Biotech
- Gilead Sciences acquisition of Tubulis Apr 2026 · US$3.1bn · Biotech
- Eli Lilly and Company acquisition of Merida Biosciences Aug 2026 · US$2.9bn · Biotech
- Merck & Co. acquisition of Terns Pharmaceuticals Mar 2026 · US$6.7bn · Biotech
- GSK acquisition of RAPT Therapeutics Jan 2026 · US$2.2bn · Biotech
Sources
- 2026 Moelis & Company: Sale to Eli Lilly and Company moelis.com
